Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders Portfolio News / Karina Tin February 8, 2024 Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders Read More »
Tenaya Therapeutics Announces Pricing of Underwritten Offering Portfolio News / Karina Tin February 8, 2024 Tenaya Therapeutics Announces Pricing of Underwritten Offering Read More »
Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader Portfolio News / Karina Tin February 1, 2024 Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader Read More »
Remix Therapeutics™ Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer Portfolio News / Karina Tin February 1, 2024 Remix Therapeutics™ Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer Read More »
Synthekine Announces Strategic Collaboration with Sanofi to Develop Selective IL-10 Agonists for Treatment of Inflammatory Diseases Portfolio News / Karina Tin January 29, 2024 Synthekine Announces Strategic Collaboration with Sanofi to Develop Selective IL-10 Agonists for Treatment of Inflammatory Diseases Read More »
Carmot Therapeutics Announces Completion of Acquisition by Roche Portfolio News / Karina Tin January 29, 2024 Carmot Therapeutics Announces Completion of Acquisition by Roche Read More »
Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies Portfolio News / Karina Tin January 23, 2024 Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies Read More »
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing Portfolio News / Karina Tin January 22, 2024 ORIC Pharmaceuticals Announces $125 Million Private Placement Financing Read More »
Tr1X Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases Portfolio News / Karina Tin January 17, 2024 Tr1X Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases Read More »
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL Portfolio News / Karina Tin January 16, 2024 Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL Read More »